layout.fixed.naaccr.doc.naaccr23.p16.html Maven / Gradle / Ivy
Go to download
Show more of this group Show more artifacts with this name
Show all versions of layout Show documentation
Show all versions of layout Show documentation
Framework that allows defining file formats (layouts) and use them to read and write data files.
The newest version!
Item #
Length
Source of Standard
Year Implemented
Version Implemented
Year Retired
Version Retired
3956
1
SEER
2022
22
NAACCR XML: Tumor.p16
DescriptionThe p16 biomarker is over-expressed (produced) in response to HPV. It is therefore a surrogate marker for HPV disease.RationalePatients with HPV have a different survival or outcome so it is important to be able to distinguish this by documenting the p16 results. Testing is performed by immunohistochemistry (IHC) which is inexpensive and has near universal availability. It has an easily standardized interpretation. HPV testing is usually performed through DNA testing which is more expensive and less widely available. HPV testing also has technically more variability with the interpretation.p16 is a tumor suppressor protein also known as cyclin-dependent kinase inhibitor 2A. The p16 biomarker is over-expressed (produced) in response to HPV. It is therefore a surrogate marker for HPV disease.Codes0 p16 Negative; Nonreactive 1 p16 Positive; Diffuse, Strong reactivity 8 Not applicable: Information not collected for this case
(If this time is required by your standard setter, use of code 8 will result in an edit error).
9 Not tested for p16; Unknown Blank Diagnosis year prior to 2021
Note: See the
SSDI Manual for coding instructions.Anus schema added/ Please note for CCCR p16 for Cervix changed from "." to RS* retroactive to 2021
© 2015 - 2024 Weber Informatics LLC | Privacy Policy